Fermented cannabinoid development green light: Amyris lands US$255m deal

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

19 Apr 2019 --- A study of cannabidiol (CBD) has found that the non-psychoactive compound in cannabis could have a new application as a “Trojan horse” – helping... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 Apr 2019 --- Innexus Nutraceuticals, based in the Netherlands, has landed a distribution deal with IMCD, a global player in sales, marketing and distribution of specialty... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

04 Apr 2019 --- The US Food and Drug Administration (FDA) has announced that it will hold a public hearing next month to discuss developing a regulatory framework for the use of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

01 Apr 2019 --- Sustainable ingredients company Amyris has reported on its first milestone for its US$300 million cannabinoid (CBD) collaboration with LAVVAN, earning its first... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

29 Mar 2019 --- In light of hemp’s recent declassification as a schedule 1 narcotic, which widened the potential for its use in the food, beverage and supplement industry,... Read More